The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in cardiovascular care.

A randomized trial of patients with a narrowing of their heart’s aortic valve, but who had not yet begun to show the symptoms ...

By The Learning Network Weekly Student News Quiz: N.B.A. First, Formal Apology, Election Have you been paying attention to current events recently? See how many of these 10 questions you can get ...

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation Receive the the latest news, research, and ...

Heartwire from Medscape, September 28, 2009 TCT CURRENT OASIS 7 PCI Analysis Doubling the dose of clopidogrel reduced the risk of MI and stent thrombosis in STEMI patients without increasing the ...

The inability of QFR to rival FFR for 1-year MACE is a reminder of the need for large studies, even when new tech is enticing ...

According to Dangas, the trial set a "very high bar" for early heparin to succeed: it had to show benefit on top of the "very ...

In older people with asymptomatic severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF), ...

The ECLIPSE trial, presented as a late-breaking study at the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, D.C., had enrolled ...

Investopedia / Mira Norian White label products are sold by retailers with their own branding and logo but the products themselves are manufactured by a third party. White labeling occurs when the ...